Genic Co. Ltd (123330) — Capital Reinvestment Ratio
Latest as of December 2025:
0.12x
Genic Co. Ltd (123330) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩7.70 Billion) in capital expenditures (₩958.13 Million). See how much free cash does Genic Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
₩7.70 Billion
KRW
Capital Expenditures
₩958.13 Million
KRW
Data as of
Dec 2025
Most recent filing
Genic Co. Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Genic Co. Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Genic Co. Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Genic Co. Ltd from 2012 to 2025. For live market cap and broader valuation context, see 123330 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | ₩20.65 Billion | ₩2.68 Billion | ▼ -97.9% |
| 2024 | 6.06x | ₩272.46 Million | ₩1.65 Billion | ▼ -24.2% |
| 2022 | 8.00x | ₩177.94 Million | ₩1.42 Billion | ▲ +3984.9% |
| 2021 | 0.20x | ₩3.32 Billion | ₩650.83 Million | ▼ -94.6% |
| 2020 | 3.62x | ₩212.66 Million | ₩769.27 Million | ▲ +499.4% |
| 2019 | 0.60x | ₩1.38 Billion | ₩830.95 Million | ▼ -86.5% |
| 2016 | 4.48x | ₩1.93 Billion | ₩8.63 Billion | ▲ +20.7% |
| 2015 | 3.71x | ₩3.63 Billion | ₩13.48 Billion | ▲ +89.2% |
| 2014 | 1.96x | ₩5.80 Billion | ₩11.39 Billion | ▼ -17.0% |
| 2013 | 2.36x | ₩3.68 Billion | ₩8.69 Billion | ▲ +130.9% |
| 2012 | 1.02x | ₩4.31 Billion | ₩4.41 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow